Eight people are diagnosed with acute myeloid leukaemia in the UK each day, accounting for over 2000 deaths each year. But a new potential therapeutic target has been uncovered, which could help improve future treatments.
Cholangiocarcinoma is a rare disease, with only two percent of patients with metastatic disease surviving past five years. But new funding is helping Cardiff University researchers to find out crucial information about this form of cancer.
Cardiff University has thanked the Leukaemia Research Appeal for Wales for 37 years of outstanding support, and for contributing more than £2.3 million to leukaemia research at the University over that time.